Special Issue "The Isoforms of the p53 Gene Family and Their Role in Cancer and Aging：Selection Papers from International p53/p63/p73 Isoforms Workshop"
Deadline for manuscript submissions: 31 December 2020.
Interests: p53/p63/p73 isoforms; epigenetic; genome reprogramming (EMT; iPSC); transcription machinery; cell fate decision; cell signaling; ECM; host-pathogens interaction; immune response
Interests: p53, p73, protein interactions, expression in cancer
The Editor of the journal Cancers has offered us the great opportunity to write a Special Issue on the isoforms of the p53 gene family. We would like to invite you to contribute to this Issue.The aims of the Issue are to review the activities and the relevance of the isoforms in the different fields of biology, giving a holistic view of their roles in the formation, maintenance, and regeneration of tissues and how their defects can lead to degenerative diseases, including cancer, ageing, auto-immune diseases, and sensitivity to infection. The Issue will also present recent progress on using isoforms in clinics and perspectives on cell therapy regarding the treatment of degenerative diseases. It will also contain a chapter recapitulating the protocols and scientific tools (antibodies, siRNA, animal models, etc.) made available to the community. We would like the Issue to be a reference in the field.
- Tissue regeneration;
- Protein structure;
- Post-translational modificaton.
Dr. Jean-Christophe Bourdon
Dr. Neda Slade
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Tissue regeneration
- Protein structure
- Post-translational modificaton